Opus Genetics, Inc. ( IRD) - Stock Earnings
IRD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
IRD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -16.5 million USD | 3.9 million USD |
| 2026Q1 | -65.5 million USD | 2.2 million USD |
| 2026Q2 | -8.1 million USD | 755000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IRD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.0 million USD | 19.0 million USD |
| 2024 | -57.5 million USD | 11.0 million USD |
| 2025 | -49.6 million USD | 14.2 million USD |
| 2026 Est. | — | — |
IRD
Price: $3.84
52 week price:
Earnings Per Share: -1.29 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 361.6 million